Schizophrenia Spectrum and Psychotic Disorders
- Protective Ethnic Density Effect Reduces Psychosis Risk in Minoritized Youth
- In-Hospital Adverse Events Similar for Haloperidol, Atypical Antipsychotics
- Few Predictors for Transition to Psychosis Have Robust Clinical Evidence
- Disappointing Results for Ulotaront in 2 Phase 3 Schizophrenia Trials
- Age-Linked Performance on Social Cognitive Tests Explored in Psychosis
- Avatar Therapy-Linked Emotions Identified in Treatment-Resistant Schizophrenia
- Changes in Gut Microbiota May Affect Etiology and Symptomology of Schizophrenia
- Sex Differences in Cognitive Impairment Identified in Schizophrenia and Tardive Dyskinesia
- Risk for Cannabis Use Disorder in Schizophrenia Increased in Young Men
- Disrupted Rest-Wakeful Rhythms Associated With Greater Schizophrenia Severity
- Long-Acting Injectable Antipsychotics May Benefit Patients With Severe Mental Illness
- Uzedy, Long-Acting Schizophrenia Treatment, Gets FDA Approval
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
